Clinical Trial Update: ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

Phase 3 ELEONOR study evaluating insulin glulisine in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin glulisine (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED